Medical Efficacy

The most important difference between these two subspecies of cannabis, however, is in their medical effects and how they influence energy levels and productivity. Indicas tend to decrease energy and are better for consumption in the evening or at night, after the conclusion of the day’s work and activities. Potent indica strains may give some patients what is called “couchlock,” a condition in which they become so relaxed that they care barely get up from the sofa.

Sativas, on the other hand, are uplifting and cerebral, enhancing creativity and productivity. Indicas provide what has been called a “body high,” while sativas deliver more of a “mind high.” Unfortunately, sativa plants require longer to grow and yield less medicine (flowers) than indica varieties. This is why indica strains have traditionally dominated those available on the black market, where there is no concern for patient need and the sole focus is profit.

The fact that patients are given no choice of subspecies or strain when purchasing from the black market is a major reason it should be avoided. Patients should never trust or consume cannabis medicine without knowing its exact strain and that it was properly grown, dried, cured, and laboratory tested for purity and potential contamination.

Modern cultivators of medical cannabis purposefully breed and grow a wide spectrum of strains within both the indica and sativa categories for the purpose of making available the right medicine for a particular patient’s unique combination of disease, preference, and lifestyle. Often, patients must maintain jobs or family responsibilities that demand a particular energy level and can’t tolerate the sedative properties of many indicas. Other times, patients must seek the most potent non-opiate painkiller possible. Given the choice of chronic pain or the mellowing effects of a strong indica of a particular strain known for its medical benefits, most patients will choose the latter.

Because cultivators and dispensaries are sensitive to the subjective efficacy of particular strains for different patients, they grow and make available as many strains as possible for targeted ailments. Major conditions of focus include HIV/AIDS, cancer, fibromyalgia, glaucoma, Parkinson’s, all types of arthritis, and epilepsy, among many others.

In terms of particular ailments, sativa strains tend to be better for psychological disorders like depression, PTSD, and anxiety. Indicas are often the best for pain and inflammation and, thus, are beneficial for patients with arthritis, fibromyalgia, and cancer. However, because so many diseases are accompanied by side effects like depression and insomnia, a patient must consider treating both their core disease and also its daily symptoms. In the end, each patient will favor multiple strains that will likely fall within the categories of sativa, hybrid, and indica.

When it comes to aroma, indica strains tend to emit musty, earthy, and skunky odors, while sativas smell sweet, fruity, or spicy. This difference in aroma is the result of terpenes, the molecules within the plant that are cousins to cannabinoids like THC and CBD. While these chemicals provide sometimes stunningly pungent odors, their greatest benefit to patients is actually their medicinal efficacy.

Understanding Hybrids

Hybrids are simply new and unique strains that are bred from parents of different types. A hybrid theoretically possesses many or most of the beneficial medical properties of both its parents. Breeders can “cross” any two strains they desire in an effort to create a new strain that delivers the best possible medical efficacy, sometimes for particular diseases like lupus, multiple sclerosis, Crohn’s disease, and epilepsy.

It should be noted that any two strains can be mixed to create a hybrid. While indica/sativa mixes are common and often noted for their “alert mellowness” and productivity, medical cannabis breeders can also mix indicas with other indicas or use two sativas as parents.

With so many hybrid strains available to patients, many are a compromise that possess the ability to kill pain and fight inflammation while not putting a patient to sleep in the middle of the day. Patients who must medicate in the morning or mid-day, typically for nausea and pain, often prefer a sativa-dominant hybrid, but will switch to an indica-dom strain in the evenings and for maximum pain relief.

Hybrid strains that display more indica than sativa traits are labeled “indica-dom,” while those that lean toward sativa are similarly dubbed “sativa-dom.” Often, strains are labeled with a sativa/indica ratio, like a 60/40 sativa/indica. Other times a strain will indicate only a percentage, such as “70 percent indica” or “80 percent sativa”.

Landrace Strains & Heirlooms

Landrace strains are those that evolved naturally within their native environments. Because they weren’t bred and aren’t hybrids, landrace strains offer a very pure example of sativa or indica, with no interference from humans. In fact, landrace strains are typically 100 percent indica or sativa, the result of tens of thousands of years of inbreeding in a particular weather climate and geography.

Heirlooms are landrace strains that have been grown outside of their native environment, such as plants or seeds professionally grown in Illinois that originated on the other side of the world. While sought for their pure indica or sativa characteristics, such strains lose some of their unique characteristics when grown outside the climate in which they evolved.

Examples of landrace strains include Durban Poison, a sativa from South Africa; Afghan Indica, from Afghanistan; Malawi Gold, a sativa from Southeastern Africa; and Panama Red, a sativa from the country that bears its name.

Landrace sativas appear in Asia, Anatolia, and Northern Africa. These climates provide the long summers and intense sun in which such strains have evolved and adapted to thrive. Indicas are located in Afghanistan, India, and Pakistan. Such strains will not reach their potential if grown within indoor or outdoor conditions that don’t match those of their native environment.

Eastern Europe, the Himalayan region of India, and Siberia are home to ruderalis landrace strains and are among the least desired of these naturally evolved plants. Often, as in the Himalayas, such plants are used to create traditional hand-rolled hash, with impoverished villagers in such regions subsisting on black market sales of the concentrate that eventually appears in smoking cafes throughout Europe.

What Determines Sativa or Indica?

Readers have already learned that the sometimes pungent aromas produced by many strains of cannabis are the result of terpenes, the special molecules in the herb that are similar in many respects to cannabinoids like THC and CBD.

While many might guess that a particular strain of cannabis is categorized as indica, sativa, or hybrid based on the presence or absence of a particular cannabinoid, or a cannabinoid in a particular volume, it is actually a terpene that determines this important status of a strain.

Myrcene, the most common terpene in cannabis, is known to help patients sleep, battling conditions like anxiety and insomnia. If present in a specific strain in a volume greater than 0.5 percent, the strain is considered an indica. If the amount of myrcene is under one half of one percent, then the strain is deemed a sativa.

This dynamic is a good example of the entourage effect, a theory that cannabinoids and terpenes work together in harmony to deliver medicinal efficacy to patients. Many terpenes buffer or enhance the effects of major cannabinoids like THC.

New Strains Constantly Being Created

New strains of cannabis, many of which are hybrids of existing strains that display exceptional analgesic (pain killing) or anti-inflammatory qualities, are being created on a regular basis. While some strains are better at dealing with the nausea associated with chemotherapy (used to treat patients with cancer and Crohn’s, among other diseases), most types of cannabis are very good at this.

With such dramatic differences between indicas and sativas in terms of medicinal efficacy and the experience of the patient, those legally using medical cannabis should work with their physician and dispensary to experiment with various strains that are already known to deliver exceptional benefits to other sufferers, especially those with the same condition.

Patients must strive to find the strains that best deal with their particular disease or ailment and its symptoms, including the side effects of any pharmaceutical drugs or therapies. This is typically not an overnight project and may require months or even years of diligent effort. In fact, patients are encouraged to continually experiment with new strains in search of greater potency or a superior cannabinoid profile that delivers improved relief.
Because this efficacy is so subjective, the advice of other patients can be given only so much weight. The true test of a particular strain of indica or sativa occurs only when used by an individual patient when they most need it, such as during bouts of pain, nausea, or insomnia.